期刊文献+

芳香化酶抑制剂相关的骨丢失及预防 被引量:1

下载PDF
导出
摘要 目前第三代芳香化酶抑制剂(Aromatase Inhibitors,AIs)已广泛应用于早期及转移性乳腺癌的辅助治疗。为绝经后激素受体阳性乳腺癌患者的治疗提供了新的一条途径。然而,由于AIs抑制绝经后乳腺癌患者体内雄激素转变为雌激素过程中芳香化酶的活性导致体内雌激素水平降低,而雌激素对骨组织具有保护作用,因此服用芳香化酶抑制剂的患者将会出现骨丢失。
出处 《实用肿瘤学杂志》 CAS 2010年第4期324-327,共4页 Practical Oncology Journal
  • 相关文献

参考文献21

  • 1Lonning PE,Geisler J.Indications and limitations of third-generation aromatase inhibitors[J].Expert Opin Invest Drugs,2008,17(5):723-739.
  • 2王利霞,施红旗,朱寿田.新辅助内分泌治疗在绝经后乳腺癌中的应用[J].实用肿瘤学杂志,2008,22(3):259-260. 被引量:6
  • 3Greep N,Giuliano A,Hansen N,et al.The effects of adjuvant chemotherapy on bone density in postmenopausal women with early breast cancer[J].Am J Med,2003,114(8):653-659.
  • 4Shapiro CL,Manola J,Leboff M.Ovarian failure after adjuvant chemotherapy is associated with rapid bone loss in women with early-stage breast cancer[J].J Clin Oncol,2001,19(14):3306-3311.
  • 5Kudchadkar R,O' Regan RM.Aromatase inhibitors as adjuvant therapy for post menopausal patients with early stage breast cancer[J].CA Cancer J Clin,2005,55(3):145-163.
  • 6Raisz LG.Pathogenesis of osteoporosis:concepts,conflicts,and p rospects[J].J Clin Invest,2005,115(12):3318-3325.
  • 7Eastell R,Adams JE,Coleman RE,et al.Effect of anastrozole on bone mineral density:5-year results from the anastrozole,tamoxifen,alone or in combination trial 18233230[J].Clin Oncol,2008,26(7):1051-1057.
  • 8Forbes JF,Cuzick J,Buzdar A,et al.Effect of anastrozole and tamoxifen asadjuvant treatment for early-stage breast cancer:100-month analysis of the ATAC trial[J].Lancet Oncol,2008,9(1):315-316.
  • 9Jakesz R,Jonat W,Gnant M,et al.Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen:combined results of ABCSG trial 8 and ARNO 95 trial[J].Lancet,2005,366(9484):455-462.
  • 10Thürlimann B,Keshaviah A,Coates AS,et al.A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer[J].N Engl J Med,2005,353:2747-2757.

二级参考文献10

共引文献5

同被引文献12

  • 1Morales L, Pans S, Verschueren K, et al. Prospective studyto assess short 一 term intra - articular and tenosynovia]changes in the aromatase inhibitor - associated arthralgiasyndrome[J].J Clin Oncol,2008,26( 19) :3147 -3152.
  • 2Dizdar 0,Ozcakar L,Malas FU,et al. Sonographic and elec-trodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia[ J]. J Clin Oncol,2009,27 (30) :4955-4960.
  • 3Santen R. Effect of endocrine therapies on bone in breastcancer patients[ J] . J Clin Endocrinol Metab,2011,96(2):308 -319.
  • 4Jingxuan W,Qingyuan Z,Shi j,et al. Immoderate inhibitionof estrogen by anastrozole enhances the severity of experi-mental polyarthritis[ J]. Exp Gerontol,2009 ,44(6 -7) :398-405.
  • 5Jingxuan W , Qingyuan Z, Shi J, et al. Genistein modulateimmune responses in collagen - induced rheumatoid arthritismodel [ J]. Maturitas, 2008 ,59(4) :405 -412.
  • 6Zhang Q, Tang D, Zhao H. Immunological therapies can re-lieve aromatase inhibitor - related joint symptoms in breastcancer survivorsf J]. Am J Clin Oncol,2010,33(6) :557 -560.
  • 7Kong YY,Feige U,Sarosi L,et al. Activated T cells regu-late bone loss and joint destruction in adjuvant arthritisthrough osteoprotegerin ligand [ J ]. Nature, 1999, 402(6759):304-309.
  • 8Georgiana K,Henry G,Rowan C,et al. Effect of denosumabon bone mineral density in women receiving adjuvant aro-matase inhibitors for non - metastatic breast cancer: sub-group analyses of a phase 3 study [ J ]. Breast Cancer Re-search and Treatment,2009,118( 1 ) :81 - 87.
  • 9Sato K, Suematsu A,Okamoto K, et al. Thl7 functions asan osteoclastogenic helper T cell subset that links T cellactivation and bone destruction [ J ]. J Exp Med, 2006,203(12):2673 -2682.
  • 10刘思佳,孙占娟,周亚欧,左晓霞.^(99)Tc-亚甲基二膦酸盐对胶原诱导性关节炎大鼠骨侵蚀的治疗作用[J].国际病理科学与临床杂志,2010,30(2):123-129. 被引量:8

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部